- Previous Close
507.90 - Open
505.06 - Bid 461.15 x 200
- Ask 527.85 x 200
- Day's Range
488.57 - 505.19 - 52 Week Range
364.17 - 616.00 - Volume
1,967,313 - Avg. Volume
2,053,947 - Market Cap (intraday)
176.214B - Beta (5Y Monthly) 1.43
- PE Ratio (TTM)
76.37 - EPS (TTM)
6.44 - Earnings Date Apr 22, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
624.78
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
www.intuitive.com15,638
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ISRG
View MorePerformance Overview: ISRG
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ISRG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ISRG
View MoreValuation Measures
Market Cap
176.21B
Enterprise Value
172.20B
Trailing P/E
76.61
Forward P/E
61.73
PEG Ratio (5yr expected)
3.40
Price/Sales (ttm)
21.32
Price/Book (mrq)
10.72
Enterprise Value/Revenue
20.62
Enterprise Value/EBITDA
61.26
Financial Highlights
Profitability and Income Statement
Profit Margin
27.81%
Return on Assets (ttm)
8.67%
Return on Equity (ttm)
15.62%
Revenue (ttm)
8.35B
Net Income Avi to Common (ttm)
2.32B
Diluted EPS (ttm)
6.44
Balance Sheet and Cash Flow
Total Cash (mrq)
4.01B
Total Debt/Equity (mrq)
0.88%
Levered Free Cash Flow (ttm)
1.2B